Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Japan Regulatory News (SJG)

Share Price Information for Schroder Japan (SJG)

Share Price is delayed by 15 minutes
Get Live Data
373.00    -5.00 (-1.32%)
Bid:
373.00
Ask:
375.00
Spread: 2.00 (0.536%)
Market Cap: £424.69m
SJG Live PriceLast checked at - London Stock Exchange

Intraday Schroder Japan Share Chart

Board Changes

4 Jul 2024 07:00

RNS Number : 0549V
Schroder Japan Trust PLC
04 July 2024
 

 

 

 

Board of Schroder Japan Trust plc

 

Board Changes

 4 July 2024

 

The Board of Schroder Japan Trust plc (the "Company") is pleased to announce the appointment of Ms Samantha Wren and Ms Merryn Somerset Webb as independent non-executive directors of the Company, with effect from 4 July 2024. Samantha will be appointed as Chair of the Audit and Risk Committee with effect from 4 July 2024, to succeed Belinda Richards who resigned from her position as a non-executive director of the Company and as Chair of the Audit and Risk Committee, with effect from 3 July 2024. Both Samantha and Merryn will become members of the Management Engagement Committee and the Nomination Committee. Merryn will also become a member of the Audit and Risk Committee.

 

Samantha Wren

 

Samantha has extensive accounting and auditing experience. She has previously held the position of Chief Executive at IPGL Limited, a private investment firm where she held a number of directorships of investee companies across a variety of sectors. Before her tenure at IPGL, she served as a board member and Group Chief Financial Officer and Group Chief Operating Officer at NEX Group plc. Earlier in her career, Samantha held various positions at The Rank Group plc, where she also served as a director of the Rank Pension Plan Trustee Limited. Samantha is a qualified Chartered Management Accountant and holds an honours degree in Economics from the University of Portsmouth. She is currently a non-executive director of Chapel Down Group plc where she chairs the remuneration committee and The City of London Investment Trust plc, where she also chairs the Audit Committee.

 

Samantha Wren holds 1,650 ordinary shares in Schroder Japan Trust plc.

 

Merryn Somerset Webb

 

Merryn is a seasoned financial expert with a comprehensive understanding of investment trusts. Known for her role as a senior columnist for Bloomberg Opinion and before that for the FT, she regularly shares her financial insights across various media. She was also Editor-in-Chief of MoneyWeek, the UK personal finance magazine. Merryn's previous non-executive directorships include Murray Income Investment Trust plc, Baillie Gifford Shin Nippon plc, Montanaro European Smaller Companies Trust plc and Netwealth Investments Limited. She is currently a director of BlackRock Throgmorton Trust plc. Early in her career, Merryn worked in Tokyo as an institutional salesperson in Japanese equities for UBS Warburg, having previously studied Japanese at SOAS (University of London) and as a Daiwa scholar in Japan.

 

Philip Kay, Chairman of the Company, said:

 

"I am delighted that Samantha and Merryn are joining the Board of Schroder Japan Trust plc. They both bring significant and highly relevant experience and knowledge to the Company. My fellow board members and I welcome Samantha and Merryn and very much look forward to working with them. The Board and I would also like to thank Belinda for her great contribution and wise counsel to the Company over the past six years."

 

There are no other details to be disclosed, in respect of Samantha Wren and Merryn Somerset Webb under Listing Rule 9.6.13R.

 

 

 

Enquiries:

 

Schroder Investment Management Limited

Katherine Fyfe (Company Secretarial)

Kirsty Preston (PR)

Tel: 020 7658 6000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSMFMDELSEEW
Date   Source Headline
10th Nov 202512:00 pmRNSNet Asset Value(s)
7th Nov 20255:17 pmRNSTransaction in Own Shares
7th Nov 202511:42 amRNSNet Asset Value(s)
6th Nov 20255:23 pmRNSTransaction in Own Shares
6th Nov 20255:23 pmRNSHolding(s) in Company
6th Nov 202511:41 amRNSNet Asset Value(s)
5th Nov 20255:23 pmRNSTransaction in Own Shares
5th Nov 202512:22 pmRNSNet Asset Value(s)
4th Nov 202511:43 amRNSNet Asset Value(s)
3rd Nov 202512:28 pmRNSNet Asset Value(s)
31st Oct 20255:21 pmRNSTotal Voting Rights
31st Oct 202511:58 amRNSNet Asset Value(s)
30th Oct 20255:11 pmRNSTransaction in Own Shares
30th Oct 202511:49 amRNSNet Asset Value(s)
29th Oct 20255:25 pmRNSTransaction in Own Shares
29th Oct 202511:48 amRNSNet Asset Value(s)
28th Oct 202511:07 amRNSNet Asset Value(s)
27th Oct 20255:18 pmRNSTransaction in Own Shares
27th Oct 202511:37 amRNSNet Asset Value(s)
24th Oct 20255:22 pmRNSTransaction in Own Shares
24th Oct 202511:35 amRNSNet Asset Value(s)
23rd Oct 202511:24 amRNSNet Asset Value(s)
22nd Oct 202511:40 amRNSNet Asset Value(s)
21st Oct 20255:39 pmRNSTransaction in Own Shares
21st Oct 202511:50 amRNSNet Asset Value(s)
20th Oct 202511:57 amRNSNet Asset Value(s)
17th Oct 20255:31 pmRNSTransaction in Own Shares
17th Oct 202511:52 amRNSNet Asset Value(s)
16th Oct 20255:16 pmRNSTransaction in Own Shares
16th Oct 202511:19 amRNSNet Asset Value(s)
15th Oct 202511:43 amRNSNet Asset Value(s)
14th Oct 202511:49 amRNSNet Asset Value(s)
13th Oct 20255:15 pmRNSTransaction in Own Shares
13th Oct 202511:59 amRNSNet Asset Value(s)
10th Oct 20253:20 pmRNS-RResults analysis from Kepler Trust Intelligence
10th Oct 202511:26 amRNSNet Asset Value(s)
9th Oct 202511:20 amRNSNet Asset Value(s)
8th Oct 202511:50 amRNSNet Asset Value(s)
8th Oct 20257:00 amRNSAnnual Financial Report
7th Oct 202511:34 amRNSNet Asset Value(s)
6th Oct 20255:06 pmRNS-RWebinar from Portfolio Manager
6th Oct 202511:54 amRNSNet Asset Value(s)
3rd Oct 202512:37 pmRNSNet Asset Value(s)
2nd Oct 202511:44 amRNSNet Asset Value(s)
1st Oct 20251:50 pmRNSTotal Voting Rights
1st Oct 202511:59 amRNSNet Asset Value(s)
30th Sep 202511:49 amRNSNet Asset Value(s)
29th Sep 202511:56 amRNSNet Asset Value(s)
26th Sep 20255:09 pmRNSHolding(s) in Company
26th Sep 20255:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.